- Home
- CATO vs HOWL Comparison
CATO vs HOWL Comparison
Compare CATO & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATO
- HOWL
- Stock Information
- Founded
- CATO 1946
- HOWL 2017
- Country
- CATO United States
- HOWL United States
- Employees
- CATO N/A
- HOWL N/A
- Industry
- CATO Clothing/Shoe/Accessory Stores
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- CATO Consumer Discretionary
- HOWL Health Care
- Exchange
- CATO Nasdaq
- HOWL Nasdaq
- Market Cap
- CATO 77.6M
- HOWL 87.4M
- IPO Year
- CATO N/A
- HOWL 2021
- Fundamental
- Price
- CATO $3.38
- HOWL $1.42
- Analyst Decision
- CATO
- HOWL Strong Buy
- Analyst Count
- CATO 0
- HOWL 2
- Target Price
- CATO N/A
- HOWL $9.50
- AVG Volume (30 Days)
- CATO 70.3K
- HOWL 280.2K
- Earning Date
- CATO 03-20-2025
- HOWL 03-06-2025
- Dividend Yield
- CATO 15.22%
- HOWL N/A
- EPS Growth
- CATO N/A
- HOWL N/A
- EPS
- CATO N/A
- HOWL N/A
- Revenue
- CATO $666,779,000.00
- HOWL $3,386,000.00
- Revenue This Year
- CATO N/A
- HOWL N/A
- Revenue Next Year
- CATO N/A
- HOWL $34.17
- P/E Ratio
- CATO N/A
- HOWL N/A
- Revenue Growth
- CATO N/A
- HOWL N/A
- 52 Week Low
- CATO $3.02
- HOWL $1.26
- 52 Week High
- CATO $7.05
- HOWL $8.19
- Technical
- Relative Strength Index (RSI)
- CATO 38.50
- HOWL 41.51
- Support Level
- CATO $3.46
- HOWL $1.28
- Resistance Level
- CATO $3.93
- HOWL $1.42
- Average True Range (ATR)
- CATO 0.18
- HOWL 0.09
- MACD
- CATO -0.01
- HOWL 0.01
- Stochastic Oscillator
- CATO 28.00
- HOWL 49.93
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories primarily in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.